Previous research has shown that treatment with α7nAChR agonists, such as nicotine [15] and choline [26], relieved preeclampsia symptoms and improved adverse fetal outcomes, including fetal loss and intrauterine growth restriction, in pregnant rats administered LPS. Here, CHRNA7 is linked to fetal growth restriction.